Johnson & Johnson is beginning a huge final study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. U.S. health officials insist the race for a vaccine isn’t cutting corners. But many vaccine specialists question whether the Food and Drug Administration will stick to that goal under intense pressure from the Trump administration. Senators were scheduled to question FDA Commissioner Stephen Hahn, Fauci and other administration officials later Wednesday about the pandemic response. J&J’s vaccine is made with slightly different technology than others in late-stage testing, modeled on an Ebola vaccine the company created.

Source: Huffington Post September 23, 2020 12:11 UTC